19.81
-0.04
(-0.20%)
At close: January 30 at 4:00:01 PM EST
19.68
-0.13
(-0.66%)
Pre-Market: 7:37:27 AM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
6,731,000.00
7,380,000.00
3,912,000.00
2,228,000.00
6,433,000.00
Investing Cash Flow
-10,431,000.00
-1,282,000.00
-2,761,000.00
-961,000.00
-2,351,000.00
Financing Cash Flow
-3,944,000.00
-606,000.00
-789,000.00
-420,000.00
71,000.00
End Cash Position
6,629,000.00
14,867,000.00
9,893,000.00
8,957,000.00
7,260,000.00
Capital Expenditure
-170,000.00
-376,000.00
-317,000.00
-252,000.00
-307,000.00
Repayment of Debt
-85,000.00
-91,000.00
-73,000.00
-58,000.00
-44,000.00
Repurchase of Capital Stock
-3,879,000.00
-564,000.00
-908,000.00
-447,000.00
--
Free Cash Flow
6,561,000.00
7,004,000.00
3,595,000.00
1,976,000.00
6,126,000.00
12/31/2020 - 6/1/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INCY Incyte Corporation
73.77
+0.07%
ASND Ascendis Pharma A/S
127.30
-0.20%
HALO Halozyme Therapeutics, Inc.
56.42
+1.06%
TLX Telix Pharmaceuticals Limited
18.20
-0.55%
RVMD Revolution Medicines, Inc.
43.07
+5.25%
EXEL Exelixis, Inc.
32.93
-0.09%
ZEAL.CO Zealand Pharma A/S
741.00
+1.30%
LEGN Legend Biotech Corporation
37.22
+3.10%
CYTK Cytokinetics, Incorporated
49.97
+2.71%
ARGX argenx SE
665.68
+1.67%